tanshinone has been researched along with Urinary Bladder Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, SF; Chiu, SC; Huang, SY; Liao, KF | 1 |
Chang, SF; Chen, CC; Chen, SP; Chiu, SC; Hsieh, TF; Huang, SY; Lee, SS; Lin, TH; Liu, HH; Pang, CY; Tsai, TH | 1 |
Chang, LC; Chuo, WH; Li, PC; Liu, CW; Tsai, TR; Wu, CL | 1 |
3 other study(ies) available for tanshinone and Urinary Bladder Neoplasms
Article | Year |
---|---|
Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Potential therapeutic roles of tanshinone IIA in human bladder cancer cells.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cisplatin; Epithelial Cells; Humans; Urinary Bladder Neoplasms | 2014 |
Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions.
Topics: Abietanes; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Stability; Drugs, Chinese Herbal; Emulsions; Excipients; Humans; Nanoparticles; Nanotechnology; Particle Size; Solubility; Surface-Active Agents; Urinary Bladder Neoplasms | 2011 |